Unusually high frequency of a 69-bp deletion within the carboxy terminus of the LMP-1 oncogene of Epstein-Barr virus detected in Burkitt's lymphoma of Turkish children

Leukemia

Volumn 12, Issue 11, 1998, Pages 1796-1805

  Tacyildiz, N ^a   Cavdar, A O ^b   Ertem, U ^a   Oksal, A ^a   Kutluay, L ^c   Uluoglu, O ^d   Lin, J C ^e,f  

^a DR SAMI ULUS CHILDREN S HOSPITAL   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c General Pathology Center   (Turkey)

^d GAZI UNIVERSITY   (Turkey)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Burkitt's lymphoma; Deletion; EBV; LMP 1 oncogene

Indexed keywords

DNA; VIRUS ANTIGEN;

ARTICLE; BURKITT LYMPHOMA; CARBOXY TERMINAL SEQUENCE; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; EPSTEIN BARR VIRUS; GEL ELECTROPHORESIS; GENE DELETION; GENE FREQUENCY; HUMAN; HUMAN TISSUE; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING; TURKEY (REPUBLIC); VIRUS ONCOGENE;

EID: 0031786594     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401203     Document Type: Article

References (21)

1. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964; 1: 702-703.
2. zur Hausen H, Schulte-Holthausen H, Klein G, Henle W, Henle G, Clifford P, Santessen L. EBV DNA in biopsies of Burkitt's lymphoma and anaplastic carcinoma of the nasopharynx. Nature 1970; 228: 1956-1958.
3. Weiss LM, Strickler JG, Warnke RA, Purtilo DT, Sklar J. Epstein-Barr viral DNA in tissue of Hodgkin's disease. Am J Pathol 1987; 129: 86-91.
4. Hanto DW, Gajl-Peczalska KJ, Frizzera G, Arthur DC, Balfour HH, McClain K, Simmons RL, Najarian JS. Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative disease occurring after renal transplantation: clinical pathological, and virological findings and implications for therapy. Ann Surg 1983; 198: 356-361.
5. Hamilton-Dutoit SJ, Pallesen G, Franzmann MB, Karkov J, Black F, Skinhoj P, Pedersen C. AIDS related lymphomas. Histopathology, immunophenotype and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization. Am J Pathol 1991; 138: 149-152.
6. Pallesen G, Hamilton-Dutoit SJ, Zhou XG. The association of Epstein-Barr virus (EBV) with T cell lymphoproliferation and Hodgkin's disease: two new developments in the EBV field. Adv Cancer Res 1993; 62: 179-239.
7. Neri A, Barriga F, Inghirami G, Knowles DM, Neequaaye J, Mag-rath IT, Dalla-Favera R. Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency syndrome-associated lymphoma. Blood 1991; 77: 1092-1095.
8. Lenoir C, Philip T, Sohier R. Burkitt type lymphoma. EBV association and cytogenetic markers in cases from various geographic locations. In: Magrath IT, O'Conor GT, Ramat B, (eds). Pathogenesis of Leukaemias and Lymphomas: Environmental Influences. Raven Press: New York 1984, pp 283-295.
9. Magrath IT. The pathogenesis of Burkitt's lymphoma. Adv Cancer Res 1990; 55: 133-270.
10. Adldinger HK, Delius H, Freese UK, Clarke J, Bornkamm GW. A putative transforming gene Jijoye virus differs from that of Epstein-Barr virus prototypes. Virology 1985; 14: 221-234.
11. Arrand JR, Young L, Tugwood JD. Two families of sequences in the small RNA-encoding region of Epstein-Barr virus (EBV) correlate with EBV types A and B. J Virol 1989; 63: 983-986.
12. Dambaugh T, Hennessy K, Chamnankit L, Kieff E. U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc Natl Acad Sci USA 1984; 81: 7632-7636.
13. Jones M, Foster L, Sheedy T, Griffin B. The EB virus genome in Daudi Burkitt's lymphoma cells has a deletion similar to that observed in a non-transforming strain (P3HR-1) of the virus. EMBO J 1984; 3: 813-821.
14. Rowe D, Heston L, Metlay J, Miller G. Identification and expressin of a nuclear antigen from thegenomic region of the Jijoye strain of Epstein-Barr virus that is missing in its non-immortalizing deletion mutant, P3HR-1. Proc Natl Acad Sci USA 1985; 82: 7429-7433.
15. Rowe M, Young LS, Cadwallader K, Petti L, Kieff E, Rickinson, AB. Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins. J Virol 1989; 63: 1031-1039.
16. Sample J, Young LS, Martin B, Chatman T, Kieff E, Rickinson AB, Kieff E. Epstein-Barr virus type 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J Virol 1990; 64: 4048-4092.
17. King W, Dambaugh T, Heller M, Dowling J, Kieff E. Epstein-Barr virus DNA. XII. A variable region of the Epstein-Barr virus genome is included in the P3HR-1 deletion. J Virol 1982; 43: 979-986.
18. Zimber U, Adldinger UK, Lenoir CM, Vuillaume M, Knebel-Doeberitz MV, Laux G, Desgranges C, Wittmann P, Freese UK, Schneider U, Bornkamm GW. Geographical prevalence of two Epstein-Barr virus types. Virology 1986; 154: 56-66.
19. Young LS, Yao QY, Rooney CM, Sculley TB, Moss DJ, Rupani H, Laux G, Bornkamm GW, Rickinson AB. New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas. J Gen Virol 1987; 68: 2853-2862.
20. Rickinson AB, Young LS, Rowe M. Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. J Virol 1987; 61: 1310-1317.
21. Kaye K, Izumi K, Kieff E. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci USA 1993; 90: 9150-9154.